Technical Information
`
`DOW™ HDPE DGDA-5004 NT 7
`High Density Polyethylene Resin 
`
`Overview
`
`DOW DGDA-5004 NT 7 High Density Polyethylene (HDPE) resin is a multi-purpose polymer designed for sheet
`extrusion and thermoforming applications, including single-serve disposables and other thin walled containers.
` 
`Main Characteristics:
`• Maximum rigidity
`• High Impact Strength
`• Good Top Load Strength
`• Optimized Shear Rheology for Good Processability
`• Complies with U.S. FDA 21 CFR 177.1520 (c) 2.2
`• Consult the regulations for complete details.
`
`Additive
`
`• Antiblock: No
`
`• Slip: No
`
`• Processing Aid: No
`
`Nominal Value (English)
`0.961 g/cm³
`0.961 g/cm³
`
`0.80 g/10 min
`57 g/10 min
`Nominal Value (English)
`
`Nominal Value (SI)
`0.961 g/cm³
`0.961 g/cm³
`
`0.80 g/10 min
`57 g/10 min
`Nominal Value (SI)
`
`4600 psi
`3500 psi
`
`31.7 MPa
`24.1 MPa
`
`Physical
`Density
`Base Density 1
`Melt Index
`190°C/2.16 kg
`190°C/21.6 kg
`Mechanical
`Tensile Strength
`Yield
`Break
`Tensile Elongation
`Yield
`Break
`Flexural Modulus - 2% Secant
`Impact
`Tensile Impact Strength 2
`Hardness
`Durometer Hardness (Shore D)
`Thermal
`Deflection Temperature Under Load
`66 psi (0.45 MPa), Unannealed
`Brittleness Temperature
`Vicat Softening Temperature
`Melting Temperature (DSC)
`Peak Crystallization Temperature (DSC)
`Additional Information
`Plaque molded and tested in accordance with ASTM D4976.
`
`7.0 %
`1000 %
`188000 psi
`Nominal Value (English)
`40.0 ft·lb/in²
`Nominal Value (English)
`66  
`Nominal Value (English)
`
`169 °F
`< -105 °F
`268 °F
`271 °F
`248 °F
`
`7.0 %
`1000 %
`1300 MPa
`Nominal Value (SI)
`84.1 kJ/m²
`Nominal Value (SI)
`66  
`Nominal Value (SI)
`
`76.1 °C
`< -76.1 °C
`131 °C
`133 °C
`120 °C
`
`Test Method
`ASTM D792
`Dow Method
`ASTM D1238
`
`Test Method
`ASTM D638
`
`ASTM D638
`
`ASTM D790B
`Test Method
`ASTM D1822
`Test Method
`ASTM D2240
`Test Method
`ASTM D648
`
`ASTM D746
`ASTM D1525
`Dow Method
`Dow Method
`
`Notes
`  These are typical properties only and are not to be construed as specifications. Users should confirm results by their own tests.
`1 Base density is estimated using the assumption that every 1000 ppm of antiblock in the finished product raises the density of the
`polymer by 0.0006 g/cm³. Base density is the estimated density of the polymer if it did not contain any antiblock.
`2 Type S
`
`® ™ Trademark of The Dow Chemical Company (“Dow”) or an affiliated company of Dow.
`
`Form No. 400-00070291en
`Rev: 2011-03-22
`
`Page: 1 of 2
`
`EX1016
`Yita v. MacNeil
`IPR2020-01139
`
`

`

`Product
`Stewardship
`
`Customer
`Notice
`
`Medical
`Applications Policy
`
`Disclaimer
`
`Additional
`Information
`
`The Dow Chemical Company and its subsidiaries (“Dow”) has a fundamental concern for all who make,
`distribute, and use its products, and for the environment in which we live. This concern is the basis for our
`Product Stewardship philosophy by which we assess the safety, health, and environmental information on
`our products and then take appropriate steps to protect employee and public health and our environment.
`The success of our Product Stewardship program rests with each and every individual involved with Dow
`products ─ from the initial concept and research, to manufacture, use, sale, disposal, and recycle of each
`product.
`
`Dow strongly encourages its customers to review both their manufacturing processes and their
`applications of Dow products from the standpoint of human health and environmental quality to ensure
`that Dow products are not used in ways for which they are not intended or tested. Dow personnel are
`available to answer your questions and to provide reasonable technical support. Dow product literature,
`including safety data sheets, should be consulted prior to use of Dow products. Current safety data sheets
`are available from Dow.
`
`NOTICE REGARDING MEDICAL APPLICATION RESTRICTIONS: Dow will not knowingly sell or sample
`any product or service (“Product”) into any commercial or developmental application that is intended for:
`a.
`long-term or permanent contact with internal bodily fluids or tissues. “Long-term” is contact which
`exceeds 72 continuous hours;
`b. use in cardiac prosthetic devices regardless of the length of time involved (“cardiac prosthetic devices”
`include, but are not limited to, pacemaker leads and devices, artificial hearts, heart valves, intra-aortic
`balloons and control systems, and ventricular bypass-assisted devices);
`c. use as a critical component in medical devices that support or sustain human life; or
`d. use specifically by pregnant women or in applications designed specifically to promote or interfere with
`human reproduction.
`
`Dow requests that customers considering use of Dow products in medical applications notify Dow so that
`appropriate assessments may be conducted. Dow does not endorse or claim suitability of its products for
`specific medical applications. It is the responsibility of the medical device or pharmaceutical manufacturer
`to determine that the Dow product is safe, lawful, and technically suitable for the intended use. DOW
`MAKES NO WARRANTIES, EXPRESS OR IMPLIED, CONCERNING THE SUITABILITY OF ANY DOW
`PRODUCT FOR USE IN MEDICAL APPLICATIONS.
`
`NOTICE: No freedom from infringement of any patent owned by Dow or others is to be inferred. Because
`use conditions and applicable laws may differ from one location to another and may change with time, the
`Customer is responsible for determining whether products and the information in this document are
`appropriate for the Customer’s use and for ensuring that the Customer’s workplace and disposal practices
`are in compliance with applicable laws and other governmental enactments. Dow assumes no obligation
`or liability for the information in this document. NO WARRANTIES ARE GIVEN; ALL IMPLIED
`WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE ARE
`EXPRESSLY EXCLUDED.
`
`NOTICE: If products are described as “experimental” or “developmental”: (1) product specifications may not be fully determined;
`(2) analysis of hazards and caution in handling and use are required; (3) there is greater potential for Dow to change specifications
`and/or discontinue production; and (4) although Dow may from time to time provide samples of such products, Dow is not obligated
`to supply or otherwise commercialize such products for any use or application whatsoever.
`
`NOTICE: This data is based on information Dow believes to be reliable, as demonstrated in controlled
`laboratory testing. They are offered in good faith, but without guarantee, as conditions and method of use
`of Dow products are beyond Dow’s control. Dow recommends that the prospective user determine the
`suitability of these materials and suggestions before adopting them on a commercial scale.
`
`To the best of our knowledge, the information contained herein is accurate and reliable as of the date of
`publication, however we do not assume any liability for the accuracy and completeness of such
`information.
`
`North America
`U.S. & Canada:
`
`Mexico:
` 
`Latin America
`Argentina:
`Brazil:
`Colombia:
`Mexico:
`
`1-800-441-4369
`1-989-832-1426
`+1-800-441-4369
`
`+54-11-4319-0100
`+55-11-5188-9000
`+57-1-219-6000
`+52-55-5201-4700
`
`Europe/Middle East
`
`Italy:
`
`South Africa
`
`Asia Pacific
`
`+800-3694-6367
`+31-11567-2626
`+800-783-825
`
`+800-99-5078
`
`+800-7776-7776
`+603-7965-5392
`
`www.dow.com
`
`This document is intended for use within Asia Pacific, North America
`
`Published: 2003-10-10
`
`© 2020 The Dow Chemical Company
`
`® ™ Trademark of The Dow Chemical Company (“Dow”) or an affiliated company of Dow.
`
`Form No. 400-00070291en
`Rev: 2011-03-22
`
`Page: 2 of 2
`
`